Derivative exercise or conversion — not an open-market buy.
Traded Jun 15, 2026 · Filed Jun 16, 2026
Steris's Sr. VP, Gen Counsel, and Sec. sold $297K of Steris shares. Nobody planned it ahead of time.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$296,968
Shares × reported transaction price
35 days after results of May 11, 2026, 51 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $205.93 on Jun 15, 2026, within 3% of its 52-week low, after a 4% drop over the previous 30 trading days
52-week range $201.85 (May 11, 2026) to $268.65 (Jan 16, 2026), 6% of the way up, from 251 adjusted closes. 30 trading days earlier: $214.40 on May 1, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.9% | −1.0% | +4.9% |
| 30 days | +9.3% | +0.3% | +8.9% |
| 90 days | +5.5% | +2.2% | +3.2% |
Past results only. Not a forecast.
Derivative exercise or conversion — not an open-market buy.
Routine share withholding; mechanical by default.
Derivative exercise or conversion — not an open-market buy.